AveXis, Inc.
DelistedCIK 1652923fmd_1K2MAWDP648GENM0PX0VH6P5HYManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2014 to Mar 31, 2018, 14 periods
Latest annual · FY2017
Millions- Operating income
- (220)
- Net income
- (218)
- Free cash flow
- (189)
Latest quarter · Q1 FY2018
Millions- Operating income
- (222)
- Net income
- (222)
- Free cash flow
- (169)
AveXis, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Operating income | -$220.4 million | -$83.4 million | 10-K 2018-02-28 · proof | |
| Net income | -$218.1 million | -$83 million | 10-K 2018-02-28 · proof | |
| Cash from operating activities | -$157.4 million | -$48 million | 10-K 2018-02-28 · proof | |
| Free cash flow | -$189.4 million | -$67.2 million | 10-K 2018-02-28 · proof | |
| Total assets | $391.6 million | $270.6 million | +44.7% | 10-K 2018-02-28 · proof |
| Total liabilities | $58.8 million | $24.4 million | +140.7% | 10-K 2018-02-28 · proof |
| Cash and cash equivalents | $324.1 million | $240.4 million | +34.8% | 10-K 2018-02-28 · proof |
- What was AveXis, Inc.'s operating income in fiscal 2017?
- AveXis, Inc. reported operating income of -$220.4 million for fiscal 2017 (the year ended Dec 31, 2017), against -$83.4 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2018. SEC
- What was AveXis, Inc.'s net income in fiscal 2017?
- AveXis, Inc. reported net income of -$218.1 million for fiscal 2017 (the year ended Dec 31, 2017), against -$83 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2018. SEC
- What was AveXis, Inc.'s cash from operating activities in fiscal 2017?
- AveXis, Inc. reported cash from operating activities of -$157.4 million for fiscal 2017 (the year ended Dec 31, 2017), against -$48 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2018. SEC
- What was AveXis, Inc.'s free cash flow in fiscal 2017?
- AveXis, Inc. reported free cash flow of -$189.4 million for fiscal 2017 (the year ended Dec 31, 2017), against -$67.2 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2018. SEC
- What are AveXis, Inc.'s total assets?
- As of Dec 31, 2017, AveXis, Inc. reported total assets of $391.6 million, against $270.6 million a year earlier (+44.7%). Source: the 10-K filed with the SEC on Feb 28, 2018. SEC
- What are AveXis, Inc.'s total liabilities?
- As of Dec 31, 2017, AveXis, Inc. reported total liabilities of $58.8 million, against $24.4 million a year earlier (+140.7%). Source: the 10-K filed with the SEC on Feb 28, 2018. SEC
- What are AveXis, Inc.'s cash and cash equivalents?
- As of Dec 31, 2017, AveXis, Inc. reported cash and cash equivalents of $324.1 million, against $240.4 million a year earlier (+34.8%). Source: the 10-K filed with the SEC on Feb 28, 2018. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1652923&period_type=annual&limit=5"Information only, not investment advice.